Jonathan Cacciatore

Jonathan Cacciatore is an experienced pharmaceutical professional currently serving as Director and Senior Program Lead for CMC at Daiichi Sankyo US since December 2023. Prior to this role, Jonathan held the position of Associate Director and CMC Team Lead for Cell Therapy at Bristol Myers Squibb, where responsibilities included leading cross-functional teams and overseeing CMC strategies for cell therapy assets. Jonathan's career spans diverse roles at Merck, Patheon Biologics, Columbia University, Bucknell University, and Symbol Technologies, showcasing expertise in commercialization, regulatory interactions, and process development for biologics and cell therapies. Jonathan holds a Ph.D. in Chemical Engineering from Columbia University, along with an M.S. and a B.S. in the same field from Columbia Engineering and Bucknell University, respectively.